United States Prosthetic Heart Valves Market Outlook to 2025 – Mechanical Heart Valves, Tissue Heart Valves and Transcatheter Heart Valves

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$4995
Buy Report

Published: July 30, 2020 Report Code: GDMECC5789DB-ST

Select Item

GlobalData’s “United States Prosthetic Heart Valves Market Outlook to 2025” is a comprehensive databook report, covering key market data on the United States Prosthetic Heart Valves market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Mechanical Heart Valves, Tissue Heart Valves and Transcatheter Heart Valves.

The United States Prosthetic Heart Valves Market report provides key information and data on:
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2015 to 2025.
• 2019 company share and distribution share data for Prosthetic Heart Valves Market.
• Global corporate-level profiles of key companies operating within the United States Prosthetic Heart Valves Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

United States Prosthetic Heart Valves is segmented as follows:

• Mechanical Heart Valves

• Tissue Heart Valves

• Transcatheter Heart Valves

Reasons to Buy

Key Reasons to Purchase – The United States Prosthetic Heart Valves Market report helps you to develop:

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Key companies covered in the “United States Prosthetic Heart Valves Market Outlook to 2025” report:
• Edwards Lifesciences Corp
• Medtronic Plc
• Abbott Laboratories

Table of Contents

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 4

2 Introduction 5

2.1 What Is This Report About? 5

2.2 Prosthetic Heart Valves Market Segmentation 5

2.3 Definitions of Markets Covered in the Report 6

3 Prosthetic Heart Valves Market, United States 8

3.1 Prosthetic Heart Valves Market, United States, Revenue ($m), 2015-2025 8

3.1.1 Mechanical Heart Valves Market, United States, Revenue ($m), by Segment, 2015-2025 10

3.1.2 Tissue Heart Valves Market, United States, Revenue ($m), by Segment, 2015-2025 12

3.1.3 Transcatheter Heart Valves Market, United States, Revenue ($m), by Segment, 2015-2025 14

3.2 Prosthetic Heart Valves Market, United States, Volume (Units), 2015-2025 16

3.2.1 Mechanical Heart Valves Market, United States, Volume (Units), by Segment, 2015-2025 18

3.2.2 Tissue Heart Valves Market, United States, Volume (Units), by Segment, 2015-2025 20

3.2.3 Transcatheter Heart Valves Market, United States, Volume (Units), by Segment, 2015-2025 22

3.3 Prosthetic Heart Valves Market, United States, Average Price ($), 2015-2025 24

3.4 Prosthetic Heart Valves Market, United States, Distribution Share by Revenue ($m), 2019 26

3.5 Prosthetic Heart Valves Market, United States, Company Share by Revenue ($m), 2019 27

4 Overview of Key Companies in United States, Prosthetic Heart Valves Market 29

4.1 Edwards Lifesciences Corp 29

4.1.1 Company Overview 29

4.2 Medtronic Plc 29

4.2.1 Company Overview 29

4.3 Abbott Laboratories 29

4.3.1 Company Overview 29

4.4 CryoLife Inc 30

4.4.1 Company Overview 30

5 Prosthetic Heart Valves Market Pipeline Products 31

6 Financial Deals Landscape 32

6.1 Private Equity 32

6.1.1 JenaValve Technology Raises USD50 Million in Equity Financing 32

7 Recent Developments 34

7.1 Corporate Communications 34

7.1.1 Mar 03, 2020: Ocular Therapeutix Provides update on interim data from the OTX-TKI Phase 1 clinical trial at the Cowen 40th Annual Health Care Conference 34

7.1.2 Jan 14, 2020: Leading national health plan selects Inovalon’s cloud-based pharmacy platform 35

7.1.3 Sep 24, 2019: Jaguar Health to host investor call to provide updates regarding development of Mytesi for the potential follow-on indication of cancer therapy-related diarrhea 36

7.1.4 Sep 19, 2019: JenaValve Technology strengthens senior leadership team in clinical affairs and operations 37

7.1.5 Jul 24, 2019: Former Medtronic Executive Sean Ginney named VP of Sales at Current Health 38

7.2 Financial Announcements 38

7.2.1 Jan 28, 2020: Beckman Coulter's Access PCT Procalcitonin Assay receives U.S. FDA 510(k) clearance 38

7.2.2 Oct 23, 2019: Edwards Lifesciences reports third quarter results 39

7.2.3 Sep 25, 2019: Katerzia, the first and only amlodipine oral suspension, 1 mg/mL, is now commercially available for pediatric patients 6 years of age and older 42

7.2.4 Sep 02, 2019: Quantum Genomics Announces Positive FDA Feedback on Phase III Program Design of Firibastat in Resistant Arterial Hypertension 44

7.2.5 Aug 28, 2019: CytoSorbents highlights recent published studies on CytoSorb 44

7.2.6 Jul 23, 2019: Edwards Lifesciences reports second quarter results for the year 2019 47

7.3 Other Significant Developments 49

7.3.1 Mar 04, 2020: CytoDyn treats first patient with Leronlimab in Phase 2 trial for GvHD under modified trial protocol 49

7.3.2 Feb 27, 2020: BIOLIFE4D CSO Dr. Ravi Birla publishes paper in prestigious APL bioengineering scholarly journal 50

7.3.3 Oct 10, 2019: CINDE announces Edwards Lifesciences invests $100 million to expand its operations in Costa Rica 51

7.4 Product News 53

7.4.1 Nov 15, 2019: OncoTherapy Science: Publication of a paper describing the anti-cancer effect of TOPK inhibitor OTS514 on multiple myeloma 53

7.5 Strategy And Business Planning 53

7.5.1 Jul 19, 2019: Midatech announces safety results from first in human study for injectable MidaCore Gold nano particle diabetes vaccine programme – MTX102 53

8 Appendix 56

8.1 Research Methodology 57

8.1.1 Coverage 57

8.1.2 Secondary Research 57

8.1.3 Primary Research 58

8.1.4 Market Modeling and Forecasting 59

8.1.5 Company Share Analysis 61

8.1.6 Distribution Share Analysis 61

8.1.7 Benchmarking 61

8.2 GlobalData Consulting 62

8.3 Contact Us 62

8.4 Disclaimer 63

Table

1.1 List of Tables

Table 1: Prosthetic Heart Valves Market, United States, Revenue ($m), USD Constant, 2015-2020 9

Table 2: Prosthetic Heart Valves Market, United States, Revenue ($m), USD Constant, 2021-2025 9

Table 3: Mechanical Heart Valves Market, United States, Revenue ($m), USD Constant, 2015-2020 11

Table 4: Mechanical Heart Valves Market, United States, Revenue ($m), USD Constant, 2021-2025 11

Table 5: Tissue Heart Valves Market, United States, Revenue ($m), USD Constant, 2015-2020 13

Table 6: Tissue Heart Valves Market, United States, Revenue ($m), USD Constant, 2021-2025 13

Table 7: Transcatheter Heart Valves Market, United States, Revenue ($m), USD Constant, 2015-2020 15

Table 8: Transcatheter Heart Valves Market, United States, Revenue ($m), USD Constant, 2021-2025 15

Table 9: Prosthetic Heart Valves Market, United States, Volume (Units), 2015-2020 17

Table 10: Prosthetic Heart Valves Market, United States, Volume (Units), 2021-2025 17

Table 11: Mechanical Heart Valves Market, United States, Volume (Units), 2015-2020 19

Table 12: Mechanical Heart Valves Market, United States, Volume (Units), 2021-2025 19

Table 13: Tissue Heart Valves Market, United States, Volume (Units), 2015-2020 21

Table 14: Tissue Heart Valves Market, United States, Volume (Units), 2021-2025 21

Table 15: Transcatheter Heart Valves Market, United States, Volume (Units), 2015-2020 23

Table 16: Transcatheter Heart Valves Market, United States, Volume (Units), 2021-2025 23

Table 17: Prosthetic Heart Valves Market, United States, Average Price ($), 2015-2020 24

Table 18: Prosthetic Heart Valves Market, United States, Average Price ($), 2021-2025 25

Table 19: Prosthetic Heart Valves Market, United States, Distribution Share by Revenue ($m), USD Constant, 2019 26

Table 20: Prosthetic Heart Valves Market, United States, Company Share by Revenue ($m), USD Constant, 2019 28

Table 21: Prosthetic Heart Valves Market Pipeline Products 31

Table 22: JenaValve Technology Raises USD50 Million in Equity Financing 32

Table 23: Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country 59

Figures

1.2 List of Figures

Figure 1: Prosthetic Heart Valves Market, United States, Revenue ($m), USD Constant, 2015-2025 8

Figure 2: Mechanical Heart Valves Market, United States, Revenue ($m), USD Constant, 2015-2025 10

Figure 3: Tissue Heart Valves Market, United States, Revenue ($m), USD Constant, 2015-2025 12

Figure 4: Transcatheter Heart Valves Market, United States, Revenue ($m), USD Constant, 2015-2025 14

Figure 5: Prosthetic Heart Valves Market, United States, Volume (Units), 2015-2025 16

Figure 6: Mechanical Heart Valves Market, United States, Volume (Units), 2015-2025 18

Figure 7: Tissue Heart Valves Market, United States, Volume (Units), 2015-2025 20

Figure 8: Transcatheter Heart Valves Market, United States, Volume (Units), 2015-2025 22

Figure 9: Prosthetic Heart Valves Market, United States, Company Share (%) 2019 27

Frequently asked questions

United States Prosthetic Heart Valves Market Outlook to 2025 – Mechanical Heart Valves, Tissue Heart Valves and Transcatheter Heart Valves standard reports
Currency USD
$4,995

Can be used by individual purchaser only

Most Popular
$9,990

Can be shared by unlimited users within one corporate location e.g. a regional office

$14,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Cardiovascular Devices reports
Medical Devices
New
PTA Peripheral DCB Catheters Pipeline by Development Stages, Segments, Region…
$4,000 | March 2024
Medical Devices
New
PCR Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Medical Devices
New
Immunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at United States Prosthetic Heart Valves Market Outlook to 2025 – Mechanical Heart Valves, Tissue Heart Valves and Transcatheter Heart Valves in real time.

  • Access a live United States Prosthetic Heart Valves Market Outlook to 2025 – Mechanical Heart Valves, Tissue Heart Valves and Transcatheter Heart Valves dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more